Truist Securities analyst Asthika Goonewardene reiterated a Buy rating and $33.00 price target on Exelixis (NASDAQ: EXEL).Earlier Exelixis and Merck ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE